Skip to the page

Data / Drug companies / Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)

Hybio Pharmaceutical Co., Ltd. (Pingshan Factory): 88 products in the FDA NDC directory, labeler code 14403

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) (labeler code 14403) lists 88 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 85 bulk ingredients, 3 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on October 16, 2026.

The request: Watch Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) (FDA labeler code 14403): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
14403
Products in commercial distribution
88
Packages
98
Finished drugs by generic name
1
Prescription products
3
Over the counter products
0
Flagged as original packager
3 of 3 products that carry the flag
Started marketing in the last 12 months
23
Earliest marketing start
April 1, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients6573.9%
Bulk ingredients for compounding2022.7%
Generic drugs (ANDA)33.4%

Products by type

TypeProductsShare
Bulk ingredients8596.6%
Prescription drugs33.4%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Liraglutide311

Dosage forms

Dosage formProductsShare
Powder8596.6%
Injection, solution33.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Semaglutide14403-0030PowderBulk ingredients for compoundingOctober 16, 2026
Tirzepatide14403-0027PowderBulk ingredientsOctober 13, 2026
Semaglutide14403-0030PowderBulk ingredients for compoundingSeptember 22, 2026
Semaglutide14403-0030PowderBulk ingredients for compoundingSeptember 22, 2026
Semaglutide14403-0024PowderBulk ingredients for compoundingSeptember 18, 2026
Semaglutide14403-0024PowderBulk ingredients for compoundingSeptember 17, 2026
Tirzepatide14403-0029PowderBulk ingredients for compoundingSeptember 16, 2026
Teriparatide14403-0013PowderBulk ingredientsMay 18, 2026
Semaglutide14403-0024PowderBulk ingredients for compoundingMay 7, 2026
Semaglutide14403-0024PowderBulk ingredients for compoundingMay 6, 2026
Semaglutide14403-0024PowderBulk ingredients for compoundingMay 6, 2026
Semaglutide14403-0024PowderBulk ingredients for compoundingMay 6, 2026
Semaglutide14403-0024PowderBulk ingredients for compoundingFebruary 5, 2026
Tirzepatide14403-0028PowderBulk ingredientsJanuary 23, 2026
Tirzepatide14403-0028PowderBulk ingredientsJanuary 23, 2026
Semaglutide14403-0024PowderBulk ingredientsDecember 12, 2025
Semaglutide14403-0024PowderBulk ingredientsDecember 12, 2025
Liraglutide14403-0021PowderBulk ingredientsDecember 12, 2025
Liraglutide14403-0021PowderBulk ingredientsDecember 12, 2025
Liraglutide14403-0021PowderBulk ingredientsDecember 12, 2025
Semaglutide14403-0018PowderBulk ingredientsDecember 12, 2025
Semaglutide14403-0018PowderBulk ingredients for compoundingDecember 12, 2025
Terlipressin acetate14403-0026PowderBulk ingredientsNovember 12, 2025
Semaglutide14403-0018PowderBulk ingredientsOctober 13, 2025
Semaglutide14403-0024PowderBulk ingredientsSeptember 4, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.